 - HIV-1 infection, as documented by a rapid HIV test or any FDA-approved HIV-1 Enzyme or Chemiluminescence Immunoassay ECIA test kit and confirmed by Western blot at any time prior to study entry or HIV antigen, plasma HIV-1 RNA, or second antibody test by a method other than rapid HIV and ECIA. Alternatively, if a rapid HIV test or any FDA-approved HIV-1 Enzyme or Chemiluminescence Immunoassay ECIA test kit is not available, two HIV-1 RNA values 2000 copiesmL at least 24 hours apart performed by any laboratory that has CLIA certification, or its equivalent, may be used to document infection. 